Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
May 14, 2024 09:25 ET
|
Merit Medical Systems, Inc.
New products broaden Merit’s leadership in embolotherapy.Full portfolio will be exhibited at the 18th Annual GEST Meeting May 16-19 in New York City. SOUTH JORDAN, Utah, May 14, 2024 (GLOBE...
XEALTH CLIENT THOUGHT LEADERS AT REUTERS EVENTS DIGITAL HEALTH 2024
May 14, 2024 09:13 ET
|
Xealth
SAN DIEGO, Calif.—REUTERS EVENTS DIGITAL HEALTH, May 14, 2024 (GLOBE NEWSWIRE) -- Xealth, the leader in enabling digital health at scale, is proud to support several clients who will be speaking at...
Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®
May 14, 2024 09:00 ET
|
Scilex Holding Company
PALO ALTO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and...
Kelso Technologies Inc. Financial Results for the Three Months Ended March 31, 2024
May 14, 2024 09:00 ET
|
Kelso Technologies Inc.
VANCOUVER, British Columbia and BONHAM, Texas, May 14, 2024 (GLOBE NEWSWIRE) -- Kelso Technologies Inc. (“Kelso” or the “Company”), (TSX: KLS), reports that it has released its unaudited...
Shuttle Pharma Provides First Quarter 2024 Corporate Update
May 14, 2024 09:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., May 14, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Xometry to Participate in Upcoming Investor Conferences
May 14, 2024 08:30 ET
|
Xometry, Inc.
Xometry to Participate in Upcoming Investor Conferences
Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week
May 14, 2024 08:30 ET
|
Veru Inc.
MIAMI, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 14, 2024 08:00 ET
|
Candel Therapeutics
Announced positive survival data from ongoing randomized phase 2 clinical trial of CAN-2409 in borderline resectable pancreatic cancerPhase 2 topline overall survival data for CAN-2409 in non-small...
Revolo Biotherapeutics to Present at Upcoming Medical Meetings in May
May 14, 2024 08:00 ET
|
Revolo Biotherapeutics
GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, May 14, 2024 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that reset the immune system to...
Theriva™ Biologics participará en la conferencia virtual de salud de A.G.P.
May 14, 2024 08:00 ET
|
Theriva Biologics, Inc.
ROCKVILLE, Md., May 14, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), empresa diversificada de fase clínica que investiga tratamientos antineoplásicos y enfermedades...